EUVIMEDEUVIMED entdecken
Crossref

Effect of abnormal semen parameters on ICSI: morphokinetics and cumulative clinical outcomes of 10,623 embryos

Andreu Quintana-Vehí, Irene Miguel-Escalada, Aida Pujol, Maria Jose Zamora, Maria Oliver, Marco Petrolo, Mariabeatrice Dal Canto, Amelia Rodríguez-Aranda, Mina Popovic

Reproductive BioMedicine Online · 2026

DOI: 10.1016/j.rbmo.2025.105272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproductive BioMedicine Online, 2026. Verfasst von Andreu Quintana-Vehí und 8 weiteren Autor:innen. Beteiligte Einrichtung: Eugin Clinic, Barcelona, Spain; Department of Cell Biology, Physiology and Immunology, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. El…. Hauptthemen laut MEDLINE: Sperm Injections, Intracytoplasmic, Semen Analysis. Die Arbeit nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RESEARCH QUESTION: Does sperm quality influence embryo morphokinetics, embryo quality and reproductive outcomes in intracytoplasmic sperm injection (ICSI) cycles? DESIGN: Retrospective cohort study (10,623 embryos from 1680 patients; 1836 ICSI cycles) conducted at a single IVF centre (2019-2023). Embryos were grouped by semen quality and origin: normozoospermia (n = 8799), severe oligozoospermia (n = 567), severe oligoasthenozoospermia (n = 716) and testicular sperm extraction (TESE) (n = 541). Time-lapse microscopy was used to assess morphokinetic parameters. Developmental and clinical outcomes were analysed for first and cumulative transfers. RESULTS: A total of 14,568 oocytes were inseminated. Normal fertilization (two pronuclei) was highest in the normozoospermia group (74.6%) and declined progressively with impaired semen quality: oligozoospermia (69.4%), oligoasthenzooospermia (68.3%) and TESE group (59.6%) (all P ≤ 0.042 versus normozoospermia). Correspondingly, the proportion of non-fertilized oocytes increased as follows: normozoospermia (9.8%), oligozoospermia (15.7%), oligoasthenozoospermia (15.8%) and TESE (22.1%) (all P ≤ 0.012 versus normozoospermia). One-pronucleus zygotes were also more frequent in the TESE group (7.2%) compared with the normozoospermia group (4.8%) (P = 0.019). The TESE-derived embryos showed accelerated cleavage from pronuclear fading to the five-cell stage (P ≤ 0.027). Blastocyst quality was reduced in the TESE and severe oligoasthenozoospermia groups. First transfer outcomes were comparable across groups; cumulative implantation, pregnancy and live birth rates per embryo transferred were lower for TESE (P ≤ 0.031). CONCLUSIONS: Semen origin significantly affects embryo development and cumulative outcomes in ICSI cycles. Although moderate impairments had limited effect, TESE-derived spermatozoa were associated with altered morphokinetics, poorer embryo quality and lower cumulative success rates. Sperm origin represents a clinically relevant factor for embryo evaluation and transfer decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sperm Injections, IntracytoplasmicSemen AnalysisHumansFemaleMaleRetrospective StudiesPregnancyAdultPregnancy RateEmbryo TransferEmbryonic DevelopmentPregnancy Outcome

Stichwörter der Autor:innen

Embryo developmentICSIReproductive outcomesSperm qualityTESE

Autor:innen und Institutionen

  • Eugin Clinic, Barcelona, Spain; Department of Cell Biology, Physiology and Immunology, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. Electronic address: aquintana@eugin.es.
  • Eugin Group, Barcelona, Spain.
  • Eugin Clinic, Barcelona, Spain.
  • Department of Cell Biology, Physiology and Immunology, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain.
  • Biogenesi, Reproductive Medicine Centre - Eugin Group, Monza, Italy.
  • Eugin Group, Barcelona, Spain; Department of Reproductive Medicine, Ghent University Hospital, Ghent, Belgium.

Zitieren

APA

Quintana-Vehí, A., Miguel-Escalada, I., Pujol, A., Zamora, M. J., Oliver, M., Petrolo, M., Dal Canto, M., Rodríguez-Aranda, A., & Popovic, M. (2026). Effect of abnormal semen parameters on ICSI: morphokinetics and cumulative clinical outcomes of 10,623 embryos. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2025.105272

Vancouver

Quintana-Vehí A, Miguel-Escalada I, Pujol A, Zamora MJ, Oliver M, Petrolo M, et al. Effect of abnormal semen parameters on ICSI: morphokinetics and cumulative clinical outcomes of 10,623 embryos. Reproductive BioMedicine Online. 2026. doi:10.1016/j.rbmo.2025.105272

BibTeX
@article{QuintanaVeh2026,
  author = {Quintana-Vehí, Andreu and Miguel-Escalada, Irene and Pujol, Aida and Zamora, Maria Jose and Oliver, Maria and Petrolo, Marco and Dal Canto, Mariabeatrice and Rodríguez-Aranda, Amelia and Popovic, Mina},
  title = {Effect of abnormal semen parameters on ICSI: morphokinetics and cumulative clinical outcomes of 10,623 embryos},
  journal = {Reproductive BioMedicine Online},
  year = {2026},
  doi = {10.1016/j.rbmo.2025.105272}
}
Kostenlos starten →